Literature DB >> 3685753

Twenty-four-hour sleep-wake function and personality patterns in chronic insomniacs and healthy controls.

D Schneider-Helmert1.   

Abstract

A comparison was made between 16 middle-aged chronic insomniacs and 16 normal sleepers, matched by age and sex, in a psychophysiological study, including polysomnographic night sleep recordings, MMPI personality profiles, testing of cognitive performance, and relaxation capability during daytime. Both objective and subjective criteria of night sleep demonstrated a clear separation of the two groups. Insomniacs had psychosomatic personality profiles. A test for unintentional sleep suggested that poor sleep function in insomniacs is related to deficient sleep-controlling mechanisms, rather than psychological trait and state factors. Only sleep onset difficulties were susceptible to situational factors. Daytime performance was not generally impaired in insomniacs, but they had greater difficulties in the morning. Subjective daytime sleepiness was significantly higher and might represent a particular psychological problem for active behavior. Interrelations of various deficiencies in sleep-wake behavior seem to delineate specific aspects of the chronic insomniac syndrome.

Entities:  

Mesh:

Year:  1987        PMID: 3685753     DOI: 10.1093/sleep/10.5.452

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  15 in total

1.  Complexity analysis of sleep and alterations with insomnia based on non-invasive techniques.

Authors:  Philip M Holloway; Maia Angelova; Sara Lombardo; Alan St Clair Gibson; David Lee; Jason Ellis
Journal:  J R Soc Interface       Date:  2014-02-05       Impact factor: 4.118

2.  Poor sleepers who do not complain of insomnia: myths and realities about psychological and lifestyle characteristics of older good and poor sleepers.

Authors:  C S Fichten; L Creti; R Amsel; W Brender; N Weinstein; E Libman
Journal:  J Behav Med       Date:  1995-04

Review 3.  (Mis)perception of sleep in insomnia: a puzzle and a resolution.

Authors:  Allison G Harvey; Nicole K Y Tang
Journal:  Psychol Bull       Date:  2011-10-03       Impact factor: 17.737

4.  Sleep quality deteriorates over a binge--abstinence cycle in chronic smoked cocaine users.

Authors:  Edward F Pace-Schott; Robert Stickgold; Amir Muzur; Pia E Wigren; Amie S Ward; Carl L Hart; Denise Clarke; Alexandra Morgan; J Allan Hobson
Journal:  Psychopharmacology (Berl)       Date:  2005-01-26       Impact factor: 4.530

5.  Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring.

Authors:  Luc Staner; Stéphane Ertlé; Peter Boeijinga; Gilbert Rinaudo; Marie Agnès Arnal; Alain Muzet; Rémy Luthringer
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

Review 6.  Insomnia: Neurophysiological and neuropsychological approaches.

Authors:  Célyne H Bastien
Journal:  Neuropsychol Rev       Date:  2011-01-20       Impact factor: 7.444

7.  Quality of life in nonorganic and organic sleep disorders: II. Correlation with objective and subjective quality of sleep and awakening.

Authors:  Wolfgang Prause; Bernd Saletu; Peter Anderer; Georg Gruber; Henriette Löffler-Stastka; Gerhard Klösch; Magdalena Mandl; Elisabeth Grätzhofer; Gerda Saletu-Zyhlarz; Heinz Katschnig
Journal:  Wien Klin Wochenschr       Date:  2003-05-30       Impact factor: 1.704

Review 8.  Sleep disturbances, psychiatric disorders, and psychotropic drugs.

Authors:  Luc Staner
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

9.  Sleep and anxiety disorders.

Authors:  Luc Staner
Journal:  Dialogues Clin Neurosci       Date:  2003-09       Impact factor: 5.986

10.  Brain Gray Matter Deficits in Patients with Chronic Primary Insomnia.

Authors:  Eun Yeon Joo; Hyun Jin Noh; Jeong-Sik Kim; Dae Lim Koo; Daeyoung Kim; Kyoung Jin Hwang; Ji Young Kim; Sung Tae Kim; Mi Rim Kim; Seung Bong Hong
Journal:  Sleep       Date:  2013-07-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.